{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:56Z","timestamp":1761100976122},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.leukres.2008.12.005","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T09:26:52Z","timestamp":1232616412000},"page":"e61-e63","source":"Crossref","is-referenced-by-count":2,"title":["Nelarabine induced complete remission in an adult with refractory T-lineage acute lymphoblastic leukemia: A case report and review of the literature"],"prefix":"10.1016","volume":"33","author":[{"given":"Panagiotis","family":"Sigalas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristomenis-Dimitrios","family":"Tourvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Moulakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Kontopidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (4)","key":"10.1016\/j.leukres.2008.12.005_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3324\/haematol.12917","article-title":"Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia","volume":"93","author":"Staal","year":"2008","journal-title":"Haematologica"},{"issue":"October (19)","key":"10.1016\/j.leukres.2008.12.005_bib2","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"issue":"January (2)","key":"10.1016\/j.leukres.2008.12.005_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.leukres.2008.12.005_bib4","first-page":"27","article-title":"Acute lymphoblastic leukemia in adults: recent progress, future directions","volume":"24","author":"Hoelzer","year":"1987","journal-title":"Semin Hematol"},{"issue":"September (18)","key":"10.1016\/j.leukres.2008.12.005_bib5","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-06-0606","article-title":"Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia\/lymphoma","volume":"12","author":"Cohen","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"October (5)","key":"10.1016\/j.leukres.2008.12.005_bib6","first-page":"540","article-title":"New approaches to acute lymphoblastic leukemia in adults: where do we go?","volume":"27","author":"Hoelzer","year":"2000","journal-title":"Semin Oncol"},{"issue":"December (11)","key":"10.1016\/j.leukres.2008.12.005_bib7","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood.V78.11.2814.2814","article-title":"Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report","volume":"78","author":"Linker","year":"1991","journal-title":"Blood"},{"issue":"March (3)","key":"10.1016\/j.leukres.2008.12.005_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1996.00394.x","article-title":"The GIMEMA ALL 0183 trial: analysis of 10-year follow-up. GIMEMA Cooperative Group, Italy","volume":"92","author":"Mandelli","year":"1996","journal-title":"Br J Haematol"},{"issue":"February (2)","key":"10.1016\/j.leukres.2008.12.005_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1200\/JCO.1997.15.2.476","article-title":"Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukaemia. Dutch Hemato-Oncology Research Group","volume":"15","author":"Dekker","year":"1997","journal-title":"J Clin Oncol"},{"issue":"September (5)","key":"10.1016\/j.leukres.2008.12.005_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11912-008-0059-y","article-title":"Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"10","author":"Ohno","year":"2008","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.leukres.2008.12.005_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/bi00889a004","article-title":"Synthesis of 9-\u03b2-D arabinofuranosylguanine","volume":"3","author":"Reist","year":"1964","journal-title":"Biochemistry"},{"issue":"November (11)","key":"10.1016\/j.leukres.2008.12.005_bib12","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1200\/JCO.1998.16.11.3607","article-title":"Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response","volume":"16","author":"Gandhi","year":"1998","journal-title":"J Clin Oncol"},{"issue":"April (4)","key":"10.1016\/j.leukres.2008.12.005_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood.V61.4.660.660","article-title":"Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells","volume":"61","author":"Cohen","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.12.005_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0008-6215(00)80531-5","article-title":"An enzymatic synthesis of purine-D-arabinonucleosides","volume":"97","author":"Krenitsky","year":"1981","journal-title":"Carbohydr Res"},{"issue":"May (15)","key":"10.1016\/j.leukres.2008.12.005_bib15","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.12.005_bib16","unstructured":"Prescribing Information, Nelarabine (Arranon), GlaxoSmithKline. Research Triangle Park, NC; October 2005."},{"key":"10.1016\/j.leukres.2008.12.005_bib17","first-page":"742","article-title":"A phase II study of 2-amino-9-j]-Darabinosyl-6methoxy-9H-purine (506U78) in patients with relapse or refractory T-lineage acute lymphoblastic leukemias (ALL) or lymphoblastic lymphoma (LBL): CALGB Study 19801","volume":"100","author":"DeAngelo","year":"2002","journal-title":"Blood"},{"issue":"October (7)","key":"10.1016\/j.leukres.2008.12.005_bib18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O","article-title":"Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy","volume":"86","author":"Thomas","year":"1999","journal-title":"Cancer"},{"issue":"June (6)","key":"10.1016\/j.leukres.2008.12.005_bib19","first-page":"505","article-title":"Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial","volume":"84","author":"Martino","year":"1999","journal-title":"Haematologica"},{"issue":"June (12)","key":"10.1016\/j.leukres.2008.12.005_bib20","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801","volume":"109","author":"DeAngelo","year":"2007","journal-title":"Blood"},{"issue":"May (15)","key":"10.1016\/j.leukres.2008.12.005_bib21","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.2005.03.199","article-title":"Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies","volume":"23","author":"Kurtzberg","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.12.005_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/blood.V106.11.150.150","article-title":"Compound GW506U78 has high single-drug activity and good feasibility in heavily pretreated relapsed T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) and offers the option for cure with stem cell transplantation (SCT)","volume":"106","author":"Goekbuget","year":"2005","journal-title":"Blood"},{"issue":"April (8)","key":"10.1016\/j.leukres.2008.12.005_bib23","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1200\/JCO.2001.19.8.2142","article-title":"Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells","volume":"19","author":"Gandhi","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608005390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608005390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T22:50:57Z","timestamp":1589496657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608005390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0145212608005390"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.12.005","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}